Atlas Trials

Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD

Clinical trial NCT04001036 · TERMINATED

Trial details

NCT number
NCT04001036
Sponsor
Iperboreal Pharma Srl
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
End Stage Renal Disease
Start date
2019-09-01
Primary completion
2022-08-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.